NCT04545814
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients with more than 4 brain metastases on MRI; Patients with target lesions that are more than 5 cm in any dimension and/or target lesions that have previously been radiated; Patients who are not surgical candidates (per neurosurgeon) and/or stereotactic radiosurgery candidates (per radiation oncologist); Patients with prior whole brain radiation therapy; Patients with leptomeningeal disease
https://ClinicalTrials.gov/show/NCT04545814